Subscribe Us

header ads

Recents

header ads

Functional Food Ingredients Market Size At Around US$ 167.5 Bn In 2030

The functional food ingredients market would grow at a CAGR of 5.51% over the predicted time frame. The market is expected to increase in value from US$ 109.09 Bn in 2022 to US$ 167.5 Bn in 2030.

Functional Food Ingredients Market Size 2021 to 2030

The on functional food ingredients Market, which provides a business strategy, research & development activities, concise outline of the market valuation, valuable insights pertaining to market share, size, supply chain analysis, competitive landscape and regional proliferation of this industry.

Download Free Sample@ https://www.precedenceresearch.com/sample/1811

Report Scope of the Functional Food Ingredients Market

Report CoverageDetails
Market Size by 2030USD 167.5 Billion
Growth Rate from 2022 to 2030

CAGR of 5.51%

North America Market Share in 202133%
Food and Beverages Market Share in 202147%
Base Year2021
Forecast Period2022 to 2030
Segments CoveredType, Source, Product, Health Benefits, Application, Geography

A recent report provides crucial insights along with application based and forecast information in the Global Functional food ingredients Market. The report provides a comprehensive analysis of key factors that are expected to drive the growth of this market. This study also provides a detailed overview of the opportunities along with the current trends observed in the Functional food ingredients market.

A quantitative analysis of the industry is compiled for a period of 10 years in order to assist players to grow in the market. Insights on specific revenue figures generated are also given in the report, along with projected revenue at the end of the forecast period.

Companies and Manufacturers Covered

The study covers key players operating in the market along with prime schemes and strategies implemented by each player to hold high positions in the industry. Such a tough vendor landscape provides a competitive outlook of the industry, consequently existing as a key insight. These insights were thoroughly analysed and prime business strategies and products that offer high revenue generation capacities were identified. Key players of the global Functional food ingredients market are included as given below:

Functional food ingredients Market Key Players

  • Archer Daniels Midland Company
  • Ingredion Incorporated
  • Golden Grain Group Limited
  • FMC Corporation
  • Omega Protein Corporation
  • NutriBiotic
  • Cargill Incorporated
  • Tate & Lyle plc
  • Roquette Frères

Market Segments

 By Type

  • Probiotics
  • Proteins & amino acids
  • Phytochemicals & plant extracts
  • Prebiotics
  • Fibers& specialty carbohydrates
  • Omega-3 fatty acids
  • Carotenoids
  • Vitamins
  • Minerals

By Source

  • Natural
  • Animal
  • Microbial
  • Plant
  • Synthetic

By Product 

  • Maltodextrin
  • Probiotics
  • Polydextrose
  • Modified Starch
  • Pectin
  • Omega-3 (epa, dha, ala)
  • Omega-6
  • Conjugated Linoleic Acid
  • Rice Protein
  • Protein Hydrolysate
  • Mung Bean Protein

By Health Benefits

  • Gut health
  • Cardiovascular health
  • Bone health
  • Immunity
  • Nutritive health
  • Weight management
  • Other health benefits

By Application 

  • Food
    • Infant food
    • Dairy products
    • Bakery products
    • Confectionery products
    • Snacks
    • Meat & other products
    • Other food applications (breakfast cereal and flours)
  • Beverages
    • Energy drinks
    • Juices
    • Health drinks
  • Personal Care
  • Pharmaceuticals
  • Animal Feed
  • Others

By Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • France
  • Asia-Pacific
    • China
    • India
    • Japan
    • South Korea
    • Malaysia
    • Philippines
  • Latin America
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (MEA)
    • GCC
    • North Africa
    • South Africa
    • Rest of the Middle East & Africa

Report Objectives

  • To define, describe, and forecast the global functional food ingredients market based on product, and region
  • To provide detailed information regarding the major factors influencing the growth of the market (drivers, opportunities, and industry-specific challenges)
  • To strategically analyze micromarkets1 with respect to individual growth trends, future prospects, and contributions to the total market
  • To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
  • To forecast the size of market segments with respect to four main regions—North America, Europe, Asia Pacific and the Rest of the World (RoW)2
  • To strategically profile key players and comprehensively analyze their product portfolios, market shares, and core competencies3
  • To track and analyze competitive developments such as acquisitions, expansions, new product launches, and partnerships in the functional food ingredients market

Table of Content

 Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Functional Food Ingredients Market 

5.1. COVID-19 Landscape: Functional Food Ingredients Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Functional Food Ingredients Market, By Type

8.1. Functional Food Ingredients Market, by Type, 2022-2030

8.1.1. Probiotics

8.1.1.1. Market Revenue and Forecast (2017-2030)

8.1.2. Proteins & amino acids

8.1.2.1. Market Revenue and Forecast (2017-2030)

8.1.3. Phytochemicals & plant extracts

8.1.3.1. Market Revenue and Forecast (2017-2030)

8.1.4. Prebiotics

8.1.4.1. Market Revenue and Forecast (2017-2030)

8.1.5. Others

8.1.5.1. Market Revenue and Forecast (2017-2030)

Chapter 9. Global Functional Food Ingredients Market, By Source

9.1. Functional Food Ingredients Market, by Source, 2022-2030

9.1.1. Natural

9.1.1.1. Market Revenue and Forecast (2017-2030)

9.1.2. Animal

9.1.2.1. Market Revenue and Forecast (2017-2030)

9.1.3. Microbial

9.1.3.1. Market Revenue and Forecast (2017-2030)

9.1.4. Plant

9.1.4.1. Market Revenue and Forecast (2017-2030)

9.1.5. Synthetic

9.1.5.1. Market Revenue and Forecast (2017-2030)

Chapter 10. Global Functional Food Ingredients Market, By Product 

10.1. Functional Food Ingredients Market, by Product, 2022-2030

10.1.1. Maltodextrin

10.1.1.1. Market Revenue and Forecast (2017-2030)

10.1.2. Probiotics

10.1.2.1. Market Revenue and Forecast (2017-2030)

10.1.3. Polydextrose

10.1.3.1. Market Revenue and Forecast (2017-2030)

10.1.4. Modified Starch

10.1.4.1. Market Revenue and Forecast (2017-2030)

10.1.5. Others

10.1.5.1. Market Revenue and Forecast (2017-2030)

Chapter 11. Global Functional Food Ingredients Market, By Health Benefits

11.1. Functional Food Ingredients Market, by Health Benefits, 2022-2030

11.1.1. Gut health

11.1.1.1. Market Revenue and Forecast (2017-2030)

11.1.2. Cardiovascular health

11.1.2.1. Market Revenue and Forecast (2017-2030)

11.1.3. Bone health

11.1.3.1. Market Revenue and Forecast (2017-2030)

11.1.4. Immunity

11.1.4.1. Market Revenue and Forecast (2017-2030)

11.1.5. Nutritive health

11.1.5.1. Market Revenue and Forecast (2017-2030)

11.1.6. Weight management

11.1.6.1. Market Revenue and Forecast (2017-2030)

11.1.7. Others

11.1.7.1. Market Revenue and Forecast (2017-2030)

Chapter 12. Global Functional Food Ingredients Market, By Application

12.1. Functional Food Ingredients Market, by Application, 2022-2030

12.1.1. Food

12.1.1.1. Market Revenue and Forecast (2017-2030)

12.1.2. Beverages

12.1.2.1. Market Revenue and Forecast (2017-2030)

12.1.3. Personal Care

12.1.3.1. Market Revenue and Forecast (2017-2030)

12.1.4. Pharmaceuticals

12.1.4.1. Market Revenue and Forecast (2017-2030)

12.1.5. Animal Feed

12.1.5.1. Market Revenue and Forecast (2017-2030)

12.1.6. Others

12.1.6.1. Market Revenue and Forecast (2017-2030)

Chapter 13. Global Functional Food Ingredients Market, Regional Estimates and Trend Forecast

13.1. North America

13.1.1. Market Revenue and Forecast, by Type (2017-2030)

13.1.2. Market Revenue and Forecast, by Source (2017-2030)

13.1.3. Market Revenue and Forecast, by Product (2017-2030)

13.1.4. Market Revenue and Forecast, by Health Benefits (2017-2030)

13.1.5. Market Revenue and Forecast, by Application (2017-2030)

13.1.6. U.S.

13.1.6.1. Market Revenue and Forecast, by Type (2017-2030)

13.1.6.2. Market Revenue and Forecast, by Source (2017-2030)

13.1.6.3. Market Revenue and Forecast, by Product (2017-2030)

13.1.6.4. Market Revenue and Forecast, by Health Benefits (2017-2030)

13.1.7. Market Revenue and Forecast, by Application (2017-2030) 

13.1.8. Rest of North America

13.1.8.1. Market Revenue and Forecast, by Type (2017-2030)

13.1.8.2. Market Revenue and Forecast, by Source (2017-2030)

13.1.8.3. Market Revenue and Forecast, by Product (2017-2030)

13.1.8.4. Market Revenue and Forecast, by Health Benefits (2017-2030)

13.1.8.5. Market Revenue and Forecast, by Application (2017-2030)

13.2. Europe

13.2.1. Market Revenue and Forecast, by Type (2017-2030)

13.2.2. Market Revenue and Forecast, by Source (2017-2030)

13.2.3. Market Revenue and Forecast, by Product (2017-2030)

13.2.4. Market Revenue and Forecast, by Health Benefits (2017-2030) 

13.2.5. Market Revenue and Forecast, by Application (2017-2030) 

13.2.6. UK

13.2.6.1. Market Revenue and Forecast, by Type (2017-2030)

13.2.6.2. Market Revenue and Forecast, by Source (2017-2030)

13.2.6.3. Market Revenue and Forecast, by Product (2017-2030)

13.2.7. Market Revenue and Forecast, by Health Benefits (2017-2030) 

13.2.8. Market Revenue and Forecast, by Application (2017-2030) 

13.2.9. Germany

13.2.9.1. Market Revenue and Forecast, by Type (2017-2030)

13.2.9.2. Market Revenue and Forecast, by Source (2017-2030)

13.2.9.3. Market Revenue and Forecast, by Product (2017-2030)

13.2.10. Market Revenue and Forecast, by Health Benefits (2017-2030)

13.2.11. Market Revenue and Forecast, by Application (2017-2030)

13.2.12. France

13.2.12.1. Market Revenue and Forecast, by Type (2017-2030)

13.2.12.2. Market Revenue and Forecast, by Source (2017-2030)

13.2.12.3. Market Revenue and Forecast, by Product (2017-2030)

13.2.12.4. Market Revenue and Forecast, by Health Benefits (2017-2030)

13.2.13. Market Revenue and Forecast, by Application (2017-2030)

13.2.14. Rest of Europe

13.2.14.1. Market Revenue and Forecast, by Type (2017-2030)

13.2.14.2. Market Revenue and Forecast, by Source (2017-2030)

13.2.14.3. Market Revenue and Forecast, by Product (2017-2030)

13.2.14.4. Market Revenue and Forecast, by Health Benefits (2017-2030)

13.2.15. Market Revenue and Forecast, by Application (2017-2030)

13.3. APAC

13.3.1. Market Revenue and Forecast, by Type (2017-2030)

13.3.2. Market Revenue and Forecast, by Source (2017-2030)

13.3.3. Market Revenue and Forecast, by Product (2017-2030)

13.3.4. Market Revenue and Forecast, by Health Benefits (2017-2030)

13.3.5. Market Revenue and Forecast, by Application (2017-2030)

13.3.6. India

13.3.6.1. Market Revenue and Forecast, by Type (2017-2030)

13.3.6.2. Market Revenue and Forecast, by Source (2017-2030)

13.3.6.3. Market Revenue and Forecast, by Product (2017-2030)

13.3.6.4. Market Revenue and Forecast, by Health Benefits (2017-2030)

13.3.7. Market Revenue and Forecast, by Application (2017-2030)

13.3.8. China

13.3.8.1. Market Revenue and Forecast, by Type (2017-2030)

13.3.8.2. Market Revenue and Forecast, by Source (2017-2030)

13.3.8.3. Market Revenue and Forecast, by Product (2017-2030)

13.3.8.4. Market Revenue and Forecast, by Health Benefits (2017-2030)

13.3.9. Market Revenue and Forecast, by Application (2017-2030)

13.3.10. Japan

13.3.10.1. Market Revenue and Forecast, by Type (2017-2030)

13.3.10.2. Market Revenue and Forecast, by Source (2017-2030)

13.3.10.3. Market Revenue and Forecast, by Product (2017-2030)

13.3.10.4. Market Revenue and Forecast, by Health Benefits (2017-2030)

13.3.10.5. Market Revenue and Forecast, by Application (2017-2030)

13.3.11. Rest of APAC

13.3.11.1. Market Revenue and Forecast, by Type (2017-2030)

13.3.11.2. Market Revenue and Forecast, by Source (2017-2030)

13.3.11.3. Market Revenue and Forecast, by Product (2017-2030)

13.3.11.4. Market Revenue and Forecast, by Health Benefits (2017-2030)

13.3.11.5. Market Revenue and Forecast, by Application (2017-2030)

13.4. MEA

13.4.1. Market Revenue and Forecast, by Type (2017-2030)

13.4.2. Market Revenue and Forecast, by Source (2017-2030)

13.4.3. Market Revenue and Forecast, by Product (2017-2030)

13.4.4. Market Revenue and Forecast, by Health Benefits (2017-2030)

13.4.5. Market Revenue and Forecast, by Application (2017-2030)

13.4.6. GCC

13.4.6.1. Market Revenue and Forecast, by Type (2017-2030)

13.4.6.2. Market Revenue and Forecast, by Source (2017-2030)

13.4.6.3. Market Revenue and Forecast, by Product (2017-2030)

13.4.6.4. Market Revenue and Forecast, by Health Benefits (2017-2030)

13.4.7. Market Revenue and Forecast, by Application (2017-2030)

13.4.8. North Africa

13.4.8.1. Market Revenue and Forecast, by Type (2017-2030)

13.4.8.2. Market Revenue and Forecast, by Source (2017-2030)

13.4.8.3. Market Revenue and Forecast, by Product (2017-2030)

13.4.8.4. Market Revenue and Forecast, by Health Benefits (2017-2030)

13.4.9. Market Revenue and Forecast, by Application (2017-2030)

13.4.10. South Africa

13.4.10.1. Market Revenue and Forecast, by Type (2017-2030)

13.4.10.2. Market Revenue and Forecast, by Source (2017-2030)

13.4.10.3. Market Revenue and Forecast, by Product (2017-2030)

13.4.10.4. Market Revenue and Forecast, by Health Benefits (2017-2030)

13.4.10.5. Market Revenue and Forecast, by Application (2017-2030)

13.4.11. Rest of MEA

13.4.11.1. Market Revenue and Forecast, by Type (2017-2030)

13.4.11.2. Market Revenue and Forecast, by Source (2017-2030)

13.4.11.3. Market Revenue and Forecast, by Product (2017-2030)

13.4.11.4. Market Revenue and Forecast, by Health Benefits (2017-2030)

13.4.11.5. Market Revenue and Forecast, by Application (2017-2030)

13.5. Latin America

13.5.1. Market Revenue and Forecast, by Type (2017-2030)

13.5.2. Market Revenue and Forecast, by Source (2017-2030)

13.5.3. Market Revenue and Forecast, by Product (2017-2030)

13.5.4. Market Revenue and Forecast, by Health Benefits (2017-2030)

13.5.5. Market Revenue and Forecast, by Application (2017-2030)

13.5.6. Brazil

13.5.6.1. Market Revenue and Forecast, by Type (2017-2030)

13.5.6.2. Market Revenue and Forecast, by Source (2017-2030)

13.5.6.3. Market Revenue and Forecast, by Product (2017-2030)

13.5.6.4. Market Revenue and Forecast, by Health Benefits (2017-2030)

13.5.7. Market Revenue and Forecast, by Application (2017-2030)

13.5.8. Rest of LATAM

13.5.8.1. Market Revenue and Forecast, by Type (2017-2030)

13.5.8.2. Market Revenue and Forecast, by Source (2017-2030)

13.5.8.3. Market Revenue and Forecast, by Product (2017-2030)

13.5.8.4. Market Revenue and Forecast, by Health Benefits (2017-2030)

13.5.8.5. Market Revenue and Forecast, by Application (2017-2030)

Chapter 14. Company Profiles

14.1. Archer Daniels Midland Company

14.1.1. Company Overview

14.1.2. Product Offerings

14.1.3. Financial Performance

14.1.4. Recent Initiatives

14.2. Ingredion Incorporated

14.2.1. Company Overview

14.2.2. Product Offerings

14.2.3. Financial Performance

14.2.4. Recent Initiatives

14.3. Golden Grain Group Limited

14.3.1. Company Overview

14.3.2. Product Offerings

14.3.3. Financial Performance

14.3.4. Recent Initiatives

14.4. FMC Corporation

14.4.1. Company Overview

14.4.2. Product Offerings

14.4.3. Financial Performance

14.4.4. Recent Initiatives

14.5. Omega Protein Corporation

14.5.1. Company Overview

14.5.2. Product Offerings

14.5.3. Financial Performance

14.5.4. Recent Initiatives

14.6. NutriBiotic

14.6.1. Company Overview

14.6.2. Product Offerings

14.6.3. Financial Performance

14.6.4. Recent Initiatives

14.7. Cargill Incorporated

14.7.1. Company Overview

14.7.2. Product Offerings

14.7.3. Financial Performance

14.7.4. Recent Initiatives

14.8. Tate & Lyle plc

14.8.1. Company Overview

14.8.2. Product Offerings

14.8.3. Financial Performance

14.8.4. Recent Initiatives

14.9. Roquette Frères

14.9.1. Company Overview

14.9.2. Product Offerings

14.9.3. Financial Performance

14.9.4. Recent Initiatives

Chapter 15. Research Methodology

15.1. Primary Research

15.2. Secondary Research

15.3. Assumptions

Chapter 16. Appendix

16.1. About Us

16.2. Glossary of Terms

Contact Us:

Precedence Research

Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada

Call: +1 774 402 6168

Email: sales@precedenceresearch.com

Website: https://www.precedenceresearch.com

 Blog: https://www.pharma-geek.com

 

Post a Comment

0 Comments